Though some HE gene modifications, such as insertions of small peptide ligands and terminal extensions with the anti-EGFR scFv425, could be incorporated into the viral genome, the resulting recombinant viruses were unable to redirect MHV to human tumor cells (Figure 2; Verheije and Rottier, unpublished data). The gene discussed is EGFR; the disease is neoplasm.